Posts

Showing posts with the label covid19

Ivermectin - FLCCC I-MASK+ Protocol for COVID-19 (January 2022)

Image
Ivermectin is a well-known, FDA-approved anti-parasite drug that has been used successfully for more than four decades to treat onchocerciasis “river blindness” and other parasitic diseases on humans. Ivermectin has also being researched for it's potential effectiveness for dengue viral infection ( Ref ,  Ref ) and even colo-rectal cancer ( Ref ). Similarly, ivermectin has also been shown to possess antiviral activity against a whole host of other RNA viruses (Zika, yellow fever, human immunodeficiency virus type 1) ( Ref ). Ivermectin  is one of the safest drugs known. It is on the WHO’s list of essential medicines, has been given 3.7 billion times around the globe, and has won the Nobel prize for its global and historic impacts in eradicating endemic parasitic infections in many parts of the world. FLCCC medical discovery of a rapidly growing published medical evidence base, demonstrating ivermectin’s unique and highly potent ability to inhibit SARS-CoV-2 replication and to supp

Treatment for Long Haulers Syndrome 2022

Image
Up to 80% of patients experience prolonged illness after COVID-19. COVID long-haulers or LHCS (Long Haul COVID Syndrome) is not only seen after the COVID infection but it is being observed in some people that have received vaccines.  According to a  study  of Mayo Clinic patients who had COVID-19, about 75% of the people suffering long COVID symptoms — defined as persistent symptoms even six months after recovery — are women. LHCS may persist for months after the acute infection and almost half of patients report reduced quality of life. Patients may suffer prolonged neuropsychological symptoms, including multiple domains of cognition. ( Ref ,  Ref ) Researchers are learning new details about the long-term effects of COVID-19. A  study shows  COVID-19 "long haulers" have a significantly higher chance of dying months after their infection. According to the paper in Nature, COVID survivors have a 59 percent higher risk of death within six months of contracting the virus.  Sympt

Lysine Therapy Interrupts Replication of Virus

Image
Story at-a-glance Lysine is an essential amino acid that has demonstrated positive results in the treatment of COVID-19, decreasing symptoms of infection in 80% of patients by 70% in the first 48 hours Treatment used an average dose of 2,000 mg with an arginine-restricted diet and no coffee or caffeine. Several of the patients had a negative PCR test within 3 days of treatment and small group showed reduction in fever from 4 to 18 hours Lysine has been well-studied and utilized against herpes simplex virus types 1 and 2; the best results were seen in patients who also restricted their arginine-rich foods More benefits of lysine include a reduction in anxiety, reduced vascular calcification, faster wound repair and lower blood pressure in people with lysine deficient diets The best way to balance your lysine and arginine levels is through dietary changes. If you supplement during a viral illness, the researchers caution to avoid zinc or calcium supplements, s